Likewise, EBV infection could account for the over-expression of PD-L1 in EBV+ DLBCL since antiviral and inflammatory cytokine responses also activate the JAK/STAT pathway. This evidence concerns the gene SOAT1 and diffuse large B-cell lymphoma.